Walid Chemlali

1.3k total citations
19 papers, 665 citations indexed

About

Walid Chemlali is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Walid Chemlali has authored 19 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Walid Chemlali's work include Genetic factors in colorectal cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Walid Chemlali is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Cancer-related Molecular Pathways (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Walid Chemlali collaborates with scholars based in France, Switzerland and Germany. Walid Chemlali's co-authors include Ivan Bièche, Sophie Vacher, Didier Meseure, Céline Callens, Rosette Lidereau, Anne Schnitzler, Nicolás André, François Lallemand, Éric Pasmant and Kinan Drak Alsibai and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Journal of Cell Science.

In The Last Decade

Walid Chemlali

19 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walid Chemlali France 15 363 288 190 113 92 19 665
Dejuan Yang China 12 332 0.9× 283 1.0× 223 1.2× 146 1.3× 85 0.9× 23 649
Tzu‐Ju Chen Taiwan 14 342 0.9× 194 0.7× 163 0.9× 130 1.2× 55 0.6× 51 591
Hyo-Sung Jeon South Korea 15 658 1.8× 260 0.9× 196 1.0× 163 1.4× 71 0.8× 25 834
Yang An China 13 407 1.1× 292 1.0× 129 0.7× 141 1.2× 37 0.4× 55 678
Zaozao Wang China 18 470 1.3× 332 1.2× 217 1.1× 185 1.6× 72 0.8× 48 802
Qicong Luo China 13 464 1.3× 261 0.9× 158 0.8× 92 0.8× 64 0.7× 22 656
Shaobin Wu China 13 489 1.3× 305 1.1× 135 0.7× 95 0.8× 55 0.6× 22 712
Hongtuan Zhang China 17 399 1.1× 210 0.7× 130 0.7× 118 1.0× 54 0.6× 21 623
Takeshi Niinuma Japan 17 617 1.7× 388 1.3× 120 0.6× 132 1.2× 90 1.0× 39 872
Alexandre Arcaro Switzerland 14 393 1.1× 209 0.7× 195 1.0× 80 0.7× 43 0.5× 20 606

Countries citing papers authored by Walid Chemlali

Since Specialization
Citations

This map shows the geographic impact of Walid Chemlali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walid Chemlali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walid Chemlali more than expected).

Fields of papers citing papers by Walid Chemlali

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walid Chemlali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walid Chemlali. The network helps show where Walid Chemlali may publish in the future.

Co-authorship network of co-authors of Walid Chemlali

This figure shows the co-authorship network connecting the top 25 collaborators of Walid Chemlali. A scholar is included among the top collaborators of Walid Chemlali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walid Chemlali. Walid Chemlali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vacher, Sophie, Elodie Girard, Julien Masliah‐Planchon, et al.. (2020). Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer. Cancers. 12(10). 2882–2882. 9 indexed citations
2.
Meseure, Didier, Sophie Vacher, Sabah Boudjemaa, et al.. (2020). Biopathological Significance of PIWI–piRNA Pathway Deregulation in Invasive Breast Carcinomas. Cancers. 12(10). 2833–2833. 8 indexed citations
3.
Giordano, Tiziana, Sudarshan Gadadhar, Satish Bodakuntla, et al.. (2019). Loss of the deglutamylase CCP5 perturbs multiple steps of spermatogenesis and leads to male infertility. Journal of Cell Science. 132(3). 30 indexed citations
4.
5.
6.
Borcoman, Édith, Philippe De La Rochère, Wilfrid Richer, et al.. (2019). Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer. OncoImmunology. 8(5). e1581556–e1581556. 63 indexed citations
7.
Garinet, Simon, G. Pignot, Sophie Vacher, et al.. (2018). High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of GPR126 in Bladder Cancer. Molecular Cancer Research. 17(2). 469–475. 18 indexed citations
8.
Cabel, Luc, Emmanuelle Jeannot, Ivan Bièche, et al.. (2018). Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma. Clinical Cancer Research. 24(22). 5767–5771. 65 indexed citations
9.
Xu, Liang, Adrien Briaux, Véronique Becette, et al.. (2018). Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609). Journal of Hematology & Oncology. 11(1). 124–124. 23 indexed citations
10.
Vacher, Sophie, Walid Chemlali, François Lallemand, et al.. (2018). High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism. PLoS ONE. 13(1). e0190619–e0190619. 73 indexed citations
11.
Coussy, Florence, François Lallemand, Sophie Vacher, et al.. (2017). Clinical value of R-spondins in triple-negative and metaplastic breast cancers. British Journal of Cancer. 116(12). 1595–1603. 28 indexed citations
12.
Richer, Wilfrid, Julien Masliah‐Planchon, Nathalie Clément, et al.. (2017). Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers. Oncotarget. 8(21). 34245–34257. 7 indexed citations
13.
Lallemand, François, Ambre Petitalot, Sophie Vacher, et al.. (2017). Involvement of the FOXO6 transcriptional factor in breast carcinogenesis. Oncotarget. 9(7). 7464–7475. 12 indexed citations
14.
Meseure, Didier, Sophie Vacher, Kinan Drak Alsibai, et al.. (2016). Expression of ANRIL –Polycomb Complexes– CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene ( EZH2/CBX7 ) Signature with Independent Prognostic Value. Molecular Cancer Research. 14(7). 623–633. 82 indexed citations
15.
Meseure, Didier, Sophie Vacher, François Lallemand, et al.. (2016). Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer. British Journal of Cancer. 114(12). 1395–1404. 76 indexed citations
16.
Bidard, François‐Clément, Sophie Vacher, Anne Schnitzler, et al.. (2016). ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas. Oncotarget. 7(45). 73337–73346. 33 indexed citations
17.
Laé, Marick, Sophie Gardrat, Sophie Rondeau, et al.. (2016). MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways. Oncotarget. 7(51). 84428–84438. 26 indexed citations
18.
Sablin, Marie-Paule, Coraline Dubot, Jerzy Klijanienko, et al.. (2016). Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas. Oncotarget. 7(30). 47418–47430. 15 indexed citations
19.
Rondeau, Sophie, Sophie Vacher, Leanne de Koning, et al.. (2015). ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. British Journal of Cancer. 112(6). 1059–1066. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dejuan Yang Breakdown of academic impact, for papers by Tzu‐Ju Chen Breakdown of academic impact, for papers by Hyo-Sung Jeon Breakdown of academic impact, for papers by Yang An Breakdown of academic impact, for papers by Zaozao Wang Breakdown of academic impact, for papers by Qicong Luo Breakdown of academic impact, for papers by Shaobin Wu Breakdown of academic impact, for papers by Hongtuan Zhang Breakdown of academic impact, for papers by Takeshi Niinuma Breakdown of academic impact, for papers by Alexandre Arcaro
Rankless by CCL
2026